Slideflow Labs

Slideflow Labs revolutionizes cancer pathology-based biomarker development through our integrated AI platform. We combine enterprise-grade software, cloud support, and low-cost hardware solutions to democratize access to cutting-edge AI biomarkers. Our physician-scientist team delivers validated solutions for biopharma companies and healthcare providers seeking to develop and deploy AI biomarkers for cancer diagnosis and treatment selection. Our platform uniquely offers local deployment options that ensure data ownership and security while maintaining methods transparency. With proven applications spanning molecular state prediction, risk estimation, and multimodal integration, Slideflow empowers organizations to accelerate drug development and improve patient care through precision medicine.